Quantification of blood-based neurovascular unit biomarkers: an analytical platform comparison study
Chloe P Allen, Dorothée J Goulet, Sophie Stukas, Andrew M Agbay, Tessa F Morelli, Tali Romero, Veronica Hirsch‐Reinshagen, Cheryl L Wellington, Mypinder S Sekhon, Jordan D Bird · 2026
Read Quantification of blood-based neurovascular unit biomarkers: an analytical platform comparison study by Chloe P Allen, Dorothée J Goulet, Sophie Stukas, Andrew M Agbay, Tessa F Morelli, Tali Romero, Veronica Hirsch‐Reinshagen, Cheryl L Wellington, Mypinder S Sekhon, Jordan D Bird (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13629343.txt.
Description
Allen and a large team present a study from twenty twenty-six comparing lab platforms for blood markers of brain injury. After cardiac arrest, such markers help forecast recovery. Thirty-two critically ill patients supply blood samples. Four markers are measured on two main platforms and one bedside device. The two main platforms agree tightly on all four markers. The bedside device agrees poorly to moderately with the reference platform. Cross-checks between the other pairings fall in between.
Cutoff values cannot travel between devices safely, they conclude. Each platform needs its own thresholds for prognosis. The study is a secondary analysis of a care-withdrawal cohort. Platform choice becomes a clinical decision, not a detail.
Catalog record
| CREATOR | Chloe P Allen, Dorothée J Goulet, Sophie Stukas, Andrew M Agbay, Tessa F Morelli, Tali Romero, Veronica Hirsch‐Reinshagen, Cheryl L Wellington, Mypinder S Sekhon, Jordan D Bird |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |